Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho

S Yamada, CM Giachelli - Bone, 2017 - Elsevier
Vascular calcification (VC) is highly prevalent in aging, diabetes mellitus, and chronic kidney
disease (CKD). VC is a strong predictor of cardiovascular morbidity and mortality in the CKD …

[HTML][HTML] Phosphate—a poison for humans?

H Komaba, M Fukagawa - Kidney international, 2016 - Elsevier
Maintenance of phosphate balance is essential for life, and mammals have developed a
sophisticated system to regulate phosphate homeostasis over the course of evolution …

[PDF][PDF] Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder

M Fukagawa, K Yokoyama, F Koiwa… - … Apheresis and Dialysis, 2013 - jsdt.or.jp
Masafumi Fukagawa, 1 Keitaro Yokoyama, 1 Fumihiko Koiwa, 1 Masatomo Taniguchi, 1
Tetsuo Shoji, 1 Junichiro James Kazama, 1 Hirotaka Komaba, 1 Ryoichi Ando, 1 Takatoshi …

[HTML][HTML] Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism

H Komaba, M Taniguchi, A Wada, K Iseki… - Kidney international, 2015 - Elsevier
Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical
symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on …

Optimal phosphate control related to coronary artery calcification in dialysis patients

Y Isaka, T Hamano, H Fujii, Y Tsujimoto… - Journal of the …, 2021 - journals.lww.com
Background In patients on maintenance dialysis, cardiovascular mortality risk is remarkably
high, which can be partly explained by severe coronary artery calcification (CAC) …

Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients …

S Yamada, K Tsuruya, T Kitazono, T Nakano - Clinical and Experimental …, 2022 - Springer
Chronic kidney disease–mineral and bone disorder (CKD–MBD) is a systemic disorder that
affects multiple organs and systems and increases the risk of morbidity and mortality in …

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD

S Yamada, T Nakano - Journal of atherosclerosis and thrombosis, 2023 - jstage.jst.go.jp
Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney
disease (CKD). Multiple factors account for the increased incidence of cardiovascular …

The cardiovascular burden in end-stage renal disease

M Cozzolino, A Galassi, F Pivari, P Ciceri… - Expanded …, 2017 - karger.com
It is well documented that chronic kidney disease patients have an extremely high risk of
developing cardiovascular (CV) disease (CVD) compared to the general population …

The importance of phosphate control in chronic kidney disease

K Tsuchiya, T Akihisa - Nutrients, 2021 - mdpi.com
A series of problems including osteopathy, abnormal serum data, and vascular calcification
associated with chronic kidney disease (CKD) are now collectively called CKD-mineral bone …

Efficacy and safety of upacicalcet in hemodialysis patients with secondary hyperparathyroidism: a randomized placebo-controlled trial

T Shigematsu, F Koiwa, Y Isaka… - Clinical Journal of the …, 2023 - journals.lww.com
Background Secondary hyperparathyroidism is a major complication of patients undergoing
hemodialysis (HD). Upacicalcet, a new injectable calcimimetic, acts on calcium-sensing …